Skip to content

The law and biological mechanism research on acupoint Fengchi for treatment of vertebrobasilar insufficiency

The law and biological mechanism research on acupoint Fengchi for treatment of vertebrobasilar insufficiency

Status
Recruiting
Phases
Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RTRCC-12002675
Enrollment
Unknown
Registered
2012-11-03
Start date
2012-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vertebrobasilar insufficiency

Interventions

canthus or larynx:Direction
60 beats / min or 120 beats / min:Frequency

Sponsors

First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. People meet the diagnostic criteria of Vertebrobasilar insufficiency; 2. People are between the ages of 40-75 years old; 3. People who voluntarily participate in this acupuncture Treatment and could cooperate with various tests; 4. People that have sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. People who have cerebral hemorrhage or true bulbar paralysis; 2. People who have aural vertigo or Ocular vertigo; 3. People whose systolic pressure is above 180mmHg or diastolic pressure is above 120mmHg; 4. People whose Glasgow coma score is less than 15 or Hasegawa's method score is less than 27.5 5. People who have serious complication or is still in a critical condition which required surgical treatment and woman during or prepare for pregnancy and lactation; 6. Patients are participating in the clinical studies of other drugs.

Design outcomes

Primary

MeasureTime frame
Transcranial Dopple;

Countries

China

Contacts

Public ContactMeng Zhihong
yj1988mzh@163.com+86 18722699933

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 5, 2026